Clinical trial
Open Uncontrolled Investigation to Assess the Efficacy and Safety of Adacolumn® Granulocytes, Monocytes / Macrophage Apheresis Device in Children and Adolescents With Active Ulcerative Colitis
NCT00781638 is registered in ClinicalTrials.gov with Otsuka Frankfurt Research Institute GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open Uncontrolled Investigation to Assess the Efficacy and Safety of Adacolumn® Granulocytes, Monocytes / Macrophage Apheresis Device in Children and Adolescents With Active Ulcerative Colitis
- Lead sponsor
- Otsuka Frankfurt Research Institute GmbH
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2008
- Completion date
- March 31, 2012
- Enrollment
- 24 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
ulcerative colitis